215 assets in Castration-Resistant Prostate Carcinoma

Immunoglobulin G1 [De-448-Lysine], Anti-(Human Epidermal Growth Factor Receptor) (Human-Mouse Monoclonal C225 ?1-Chain) Fusion Protein With Peptide Linker (Ggggs)2 Fusion Protein With Immunoglobulin Anti-(Human Epidermal Growth Factor Receptor Her3) (Human Clone Her3.H3 Single-Chain Variable Fragment Vh-(Ggggs)3-Vl), Complex With Human-Mouse Monoclonal C225 ?-Chain, Dimer, 214??,214???,222,222?,228,228?,231,231?-Octakis(Thioether) With (2S)-N-(Carboxymethyl)-2-(3-Mercapto-2,5-Dioxo-1-Pyrrolidinyl)-?-Alanylglycylglycyl-L-Phenylalanyl-N-[[(1S)-2-[[(1S,9S)-9-Ethyl-5-Fluoro-2,3,9,10,13,15-Hexahydro-9-Hydroxy-4-Methyl-10,13-Dioxo-1H,12H-Benzo[De]Pyrano[3?,4?:6,7]Indolizino[1,2-B]Quinolin-1-Yl]Amino]-1-Methyl-2-Oxoethoxy]Methyl]Glycinamide

Lenvatinib

Palbociclib

Rucaparib

Sorafenib

Zanzalintinib

Fuzuloparib

Hyaluronidase Zzxf

Immunotherapic Bifunctional Fusion Protein Comprised Of A Fully Human Igg1 Monoclonal Antibody (Avelumab) Against Human Programmed Death-Ligand 1 (Pd-L1) Fused To The Soluble Extracellular Domain Of Transforming Growth Factor-.Beta. (Tgf-.Beta.) Receptor Ii, Which Acts As A Tgf-.Beta. Trap

[177lu]ludotadipep

Adebrelimab

Atirmociclib

Bn-Brachyury

Disitamab Vedotin

Dota-Huj-591-Gs

Evofosfamide

Golimumab

Histrelin

pf-07248144

Ptvg-Ar

Ptvg-Hp

Retlirafusp Alfa

Sacituzumab Tirumotecan

Tagitanlimab

Tislelizumab

tqb3616

Vepdegestrant

Vorinostat

Berzosertib

Bet Bromodomain Inhibitor Zen-3694

Fludeoxyglucose

Memantine Hydrochloride

Nogapendekin Alfa Inbakicept

Technetium Tc-99M Cation, Unspecified

Tuvusertib

Vipivotide Tetraxetan Gallium Ga-68

YL201 for

Avelumab

161Tb-NYM032

Abemaciclib

Anti-Steap1 Car T-Cells

Decitabine

Fludarabine

Inv-9956

Ruxolitinib

Talogreptide Mesaroxetan

177lu-betabart

177lu htk03170

68Ga-HTK03149

ab-3028